Filing Details

Accession Number:
0001181431-13-031712
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-30 19:35:32
Reporting Period:
2013-05-28
Filing Date:
2013-05-30
Accepted Time:
2013-05-30 19:35:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386858 Hyperion Therapeutics Inc HPTX Pharmaceutical Preparations (2834) 611512713
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288452 Bay City Capital Llc 750 Battery Street
Suite 400
San Francisco CA 94111
No No Yes No
1401826 Bay City Capital Fund V, L.p. C/O Bay City Capital Llc
750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
1409813 Bay City Capital Fund V Co-Investment Fund, L.p. C/O Bay City Capital Llc
750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
1461543 Bay City Capital Management V Llc C/O Bay City Capital Llc
750 Battery Street, Suite 400
San Francisco CA 94111
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-28 11,776 $21.08 2,266,256 No 4 S Direct
Common Stock Disposition 2013-05-28 224 $21.08 43,183 No 4 S Direct
Common Stock Disposition 2013-05-30 5,266 $21.00 2,260,990 No 4 S Direct
Common Stock Disposition 2013-05-30 100 $21.00 43,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management V LLC, a Delaware limited liability company ("Management V"), Bay City Capital Fund V, L.P., a Delaware limited partnership ("Fund V"), and Bay City Capital Fund V Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment V") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management V is the general partner of Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V. BCC, the manager of Management V, is also an advisor to Fund V and Co-Investment V and has sole voting and dispositive power with respect to the securities held by Fund V and Co-Investment V.
  2. Represents securities held by Fund V, including indirect interests of BCC and Management V. BCC and Manangement V each disclaim beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
  3. Represents securities held by Co-Investment V, including indirect interests of BCC and Management V. BCC and Manangement V each disclaim beneficial ownership with respect to these securities, except to the extent of their pecuniary interest therein.
  4. This transaction was executed in multiple trades at prices ranging from $21.00 to $21.37. The price reported above reflects the weighted average sale price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.